XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Revenue:        
Licensing revenue
Expenses:        
Research and development 818,629 6,167,074 2,275,045 12,934,058
General and administrative 1,689,553 3,137,008 4,153,112 6,116,063
Total expenses 2,508,182 9,304,082 6,428,157 19,050,121
Loss before other income (2,508,182) (9,304,082) (6,428,157) (19,050,121)
Other income (loss):        
Interest income 92,975 90,849 175,909 151,392
Interest expense (659,860) (848,395) (1,352,647) (2,171,110)
Other income (loss), net (8,134) 7,276 (7,292) 3,504
Gain (loss) on warrant derivative liabilities 73,613 (4,303,945) 527,025 (4,336,066)
Net loss $ (3,009,588) $ (14,358,297) $ (7,085,162) $ (25,402,401)
Basic and diluted net loss per share $ (0.10) $ (0.60) $ (0.25) $ (1.20)
Basic and diluted weighted-average shares outstanding 30,283,814 23,178,389 28,845,650 21,065,708